Novocure’s Tumor Treating Fields: Innovative brain cancer therapy with survival and safety benefitsIntroduction to brain cancer research at Novocure By Uri Weinberg Produced by Twitter Facebook Email The three most common types of brain tumour are intracranial metastases, which spread from other ...
” says Juanita Lopez, from the Institute of Cancer Research. “This encouraging early study suggests some patients with advanced brain cancer who are EB1-positive could be treated with lisavanbulin, a targeted drug which blocks
Overall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which harness the power of the immune system to attack cancer cells, have garnered excitement in recent years for their potential to revolutionize the trea...
Breast cancerBrain metastasisPalliative chemotherapyEribulinWhole brain radiation therapyBrain metastasis (BM) from breast cancer has a very poor prog- nosis, with a one-year survival rate of only 20%. The cytotoxic agents may not cross the blood—brain barrier (BBB), so their effec- tiveness ...
brain barrier, rendering them a promising means of delivering drugs to treat brain tumors.114,115In a recent study, neutrophils were utilized to deliver paclitaxel (PTX)-loaded liposomes to the brain, leading to the suppression of post-surgical glioma recurrence and improved survival rates in mice...
A gene therapy that delivers a protein that suppresses the development of female reproductive organs may improve survival rates in patients with ovarian cancer that has recurred after chemotherapy. Recurrence happens 70 percent of the time and is invariably fatal. ...
embryonic stem cells can be used more widely in treatments. For example, scientists need to develop ways to control the differentiation of embryonic stem cells into specific cell types, and they need to find ways to prevent the cells from forming cancer cells when they are transplanted into the...
Glioblastoma (GBM) is the most frequent and aggressive brain tumor in adults with the lowest survival rates five years post-diagnosis. Oncolytic viruses (OVs) selectively target and damage cancer cells, and fo... Alberto Reale, Andrea Gatta, Amruth Kaleem Basha Shaik, Mariam Shallak, Anna Mari...
(i.e., from one part of the body to another through the lymph or blood) these three characteristics distinguish cancer from benign tumors [2]. The survival rates for cancer have significantly risen since the beginning of the twenty-first century due to the development of more precise and ...
Current evidence suggests that breast cancer (BC) accounted for 11.7% of all cancer types in 2020, surpassing lung cancer as the most prevalent cancer [172]. Recent advances in therapeutic approaches have improved BC patient survival and quality of life, but mortality rates remain high due to ...